Filter
157
Filtered Results: 157
Text search:
omicron
Featured
Recommendations
28
New Publications
6
Language
Document type
Guidelines
57
Studies & Reports
32
Fact sheets
18
Strategic & Response Plan
14
Situation Updates
10
No document type
9
Training Material
7
Manuals
5
Infographics
3
Videos
2
Countries / Regions
Brazil
9
Global
8
Latin America and the Carribbean
8
Africa
5
Kenya
4
Mozambique
4
Ukraine
3
Syria
2
Philippines
2
Germany
2
Argentina
2
South Africa
2
Ethiopia
2
El Salvador
1
Turkey
1
Sierra Leone
1
Nigeria
1
Senegal
1
Burundi
1
Peru
1
Asia
1
Venezuela
1
Jordan
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Southern Africa
1
Lebanon
1
Eastern Europe
1
Moldova
1
Russia
1
Namibia
1
Egypt
1
Angola
1
Chad
1
South Sudan
1
Iraq
1
Liberia
1
India
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
54
Women & Child Health
8
Public Health
7
Key Resources
7
Clinical Guidelines
4
Capacity Building
3
Pharmacy & Technologies
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
88
Caregiver
8
Planetary Health
8
Refugee
6
Conflict
6
Health Financing Toolbox
4
Mental Health
3
TB
3
Global Health Education
3
Natural Hazards
2
Disability
2
Pharmacy
2
NCDs
2
Polio
1
AMR
1
COVID-19 Situation Update OPS/WHO Argentina: 10 February 2022
Situation report generated by the OPS/WHO representation in Argentina
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
More than two years since the first SARS-CoV-2 infections were reported, the COVID-19 pandemic remains an acute global emergency. In this Strategic Preparedness, Readiness and Response plan for 2022, WHO sets out a number of key strategic adjustments that, if implemented rapidly and consistently at ...
What every clinician should know
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
Updated Treatment Guidelines
Countries reported disruptions in all health-care settings. In more than half of countries surveyed, many people are still unable to access care at the primary care and community care levels. Significant disruptions have also been reported in emergency care, particularly concerning given the impact...
The COVID-19 CARE pathway is a living tool to support health care workers visualize the current clinical and therapeutic recommendations to be considered in the care planning for patients with COVID-19.
The COVID-19 CARE pathway is aligned with the eighth version of the WHO Therapeutics and COVID...
